Ignite Creation Date:
2024-05-06 @ 7:48 AM
Last Modification Date:
2024-10-26 @ 11:52 AM
Study NCT ID:
NCT02601014
Status:
COMPLETED
Last Update Posted:
2022-02-03
First Post:
2015-08-21
Brief Title:
Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03-15
Start Date Type:
ACTUAL
Primary Completion Date:
2020-12-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-10-06
Completion Date Type:
ACTUAL
First Submit Date:
2015-08-21
First Submit QC Date:
November 6 2015
Study First Post Date:
2015-11-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2022-02-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-06
Last Update Post Date:
2022-02-03
Last Update Post Date Type:
ACTUAL